Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells

Brain tumor glioblastoma is one of the worst types of cancer. The blood–brain barrier prevents drugs from reaching brain cells and shields glioblastoma from treatment. The creation of nanocarriers to improve drug delivery and internalization effectiveness may be the solution to this issue. In this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziganshina, Albina Y., Mansurova, Elina E., Voloshina, Alexandra D., Lyubina, Anna P., Amerhanova, Syumbelya K., Shulaeva, Marina M., Nizameev, Irek R., Kadirov, Marsil K., Bakhtiozina, Leysan R., Semenov, Vyacheslav E., Antipin, Igor S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864328/
https://www.ncbi.nlm.nih.gov/pubmed/36677608
http://dx.doi.org/10.3390/molecules28020551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864328/
https://www.ncbi.nlm.nih.gov/pubmed/36677608
http://dx.doi.org/10.3390/molecules28020551

Ejemplares similares